Go to
JCI Insight
Citations to this article
Abstract
Authors
Andreas Herrmann, Saul J. Priceman, Piotr Swiderski, Maciej Kujawski, Hong Xin, Gregory A. Cherryholmes, Wang Zhang, Chunyan Zhang, Christoph Lahtz, Claudia Kowolik, Steve J. Forman, Marcin Kortylewski, Hua Yu
Citation information
Citations to this article (13)
| Title and authors | Publication | Year |
|---|---|---|
|
The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development.
Zhang C, Wei S, Dai S, Li X, Wang H, Zhang H, Sun G, Shan B, Zhao L |
Journal for ImmunoTherapy of Cancer | 2023 |
|
A cellular census of human peripheral immune cells identifies novel cell states in lung diseases
D Song, F Yan, H Fu, L Li, J Hao, Z Zhu, L Ye, Y Zhang, M Jin, L Dai, H Fang, Z Song, D Wu, X Wang |
Clinical and Translational Medicine | 2021 |
|
STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth
C Zhang, C Yue, A Herrmann, J Song, C Egelston, T Wang, Z Zhang, W Li, H Lee, M Aftabizadeh, YJ Li, PP Lee, S Forman, G Somlo, P Chu, L Kruper, J Mortimer, DS Hoon, W Huang, S Priceman, H Yu |
Cell Metabolism | 2020 |
|
Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3
CL Esposito, S Nuzzo, ML Ibba, L Ricci-Vitiani, R Pallini, G Condorelli, S Catuogno, V de Franciscis |
Cancers | 2020 |
|
Blocking leptin‐STAT3 axis‐induced fatty acid oxidation: A novel approach to activate CD8 + T effector cells in breast cancer
J Ruan |
Thoracic Cancer | 2020 |
|
Blocking leptin‐STAT3 axis‐induced fatty acid oxidation: A novel approach to activate CD8 + T effector cells in breast cancer
J Ruan |
Thoracic Cancer | 2020 |
|
Integrin α6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells
A Herrmann, C Lahtz, J Song, M Aftabizadeh, GA Cherryholmes, H Xin, T Adamus, H Lee, D Grunert, B Armstrong, P Chu, C Brown, M Lim, S Forman, H Yu |
Oncogene | 2019 |
|
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
CL Esposito, S Nuzzo, S Catuogno, S Romano, F de Nigris, V de Franciscis |
Molecular Therapy — Nucleic Acids | 2018 |
|
L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway
E Bai, L Yang, Y Xiang, W Hu, C Li, J Lin, X Dai, G Liang, R Jin, C Zhao |
Cancer management and research | 2018 |
|
Gene and Cell Therapy: Biology and Applications
GR Jayandharan |
2018 | |
|
A novel STAT3 inhibitor HO-3867 induces cell apoptosis by reactive oxygen species-dependent endoplasmic reticulum stress in human pancreatic cancer cells:
Y Hu, C Zhao, H Zheng, K Lu, D Shi, Z Liu, X Dai, Y Zhang, X Zhang, W Hu, G Liang |
Anti-Cancer Drugs | 2017 |
|
A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect
BT Huang, WY Lai, YC Chang, JW Wang, SD Yeh, EP Lin, PC Yang |
Molecular Therapy - Nucleic Acids | 2017 |
|
Recent advances in siRNA delivery
C Sarisozen, G Salzano, VP Torchilin |
BioMolecular Concepts | 2015 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)